ArticleCancers2022

Prolonged Exposition with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) May Provide Survival Benefit after Cytoreductive Surgery (CRS) in Advanced Primary Epithelial Ovarian, Fallopian Tube, and Primary Peritoneal Cancer.

Miklos Acs et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.